Ensuring Black Lives Matter in Drug Development

Ther Innov Regul Sci. 2021 Jan;55(1):245-246. doi: 10.1007/s43441-020-00232-1. Epub 2020 Oct 22.

Authors

William E Fitzsimmons^{1

2

3}, Clara Okorie-Awé⁴

Affiliations

¹ Department of Physiology and Biophysics, College of Medicine, University of Illinois at Chicago, Chicago, USA. wfitzsim@uic.edu.
² Tutela Pharmaceuticals Inc, Vernon Hills, IL, USA. wfitzsim@uic.edu.
³ , Vernon Hills, USA. wfitzsim@uic.edu.
⁴ Diversity and Inclusion, College of Pharmacy, University of Illinois at Chicago, Chicago, USA.

No abstract available

Publication types

Letter

MeSH terms

Black or African American
COVID-19
Child
Drug Development
Humans
Male
Pandemics
Racism*
SARS-CoV-2